Feedback / Questions
ACU193 - Acumen Pharma
https://www.globenewswire.com/news-release/2022/10/24/2539885/0/en/Acumen-s-ACU193-an-Anti-Amyloid-Beta-Oligomer-Antibody-Granted-FDA-Fast-Track-Designation-for-Alzheimer-s-Disease.html
Oct 24, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next